A Phase I, Single Center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Intravenous AZD9742 in Healthy Male and Female Japanese Subjects.
Phase of Trial: Phase I
Latest Information Update: 06 Aug 2010
At a glance
- Drugs AZD 9742 (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections
- Focus Adverse reactions
- Sponsors AstraZeneca
- 06 Aug 2010 Actual patient number is 35 as reported by ClinicalTrials.gov.
- 29 Jul 2010 Actual initiation date added to 1 Apr 2010 as reported by ClinicalTrials.gov.
- 29 Jul 2010 Actual end date added to 1 Jul 2010 as reported by ClinicalTrials.gov.